Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
収録刊行物
-
- J Clin Oncol
-
J Clin Oncol 25 1658-1664, 2007